CONSTELLATION PHARMACEUTICALS INC — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0b0b0fed-c34d-4b74-a123-c20cf056e49a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-124.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007783 |
| FY 2019 | $-86.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009735 |
| FY 2018 | $-61.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007860 |
| FY 2017 | $-39.1M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007860 |
| FY 2016 | $-33.7M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-007860 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CONSTELLATION PHARMACEUTICALS INC — all facts · Revenue · Net Income